ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,550
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Final phase Ib data for the oral c‐Met inhibitor tepotinib in patients with previously treated advanced hepatocellular carcinoma
Author(s):
SJ Faivre
,
J-F Blanc
,
P. Merle
Publication date:
2016
Journal:
Ann Oncol
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Religie & Samenleving
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
1,550
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression
Authors:
Thomas Decaens
,
Carlo Barone
,
Eric Assenat
…
Tepotinib (code C88314) [Internet]
Authors:
1255P health utility with tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC)
Authors:
N Reinmuth
,
S. Popat
,
L Paz-Ares
See all similar
Cited by
1
Translational pharmacokinetic‐pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose
Authors:
Wenyuan Xiong
,
Manja Friese-Hamim
,
Andreas Johne
…
See all cited by